Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The 1991 Elis Berven Lecture. Radiotherapy in the nineties. Increase in cure, decrease in morbidity.

S Dische1

  • 1Marie Curie Research Wing for Oncology, Mount Vernon Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, Middlesex, UK.

Acta Oncologica (Stockholm, Sweden)
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CHART revisited: a conservative approach for advanced head and neck cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2007
Same author

From CHART to CHARTWEL in non-small cell lung cancer: clinical radiobiological modelling of the expected change in outcome.

Clinical oncology (Royal College of Radiologists (Great Britain))·2003
Same author

Translational Research--a new entity?

Acta oncologica (Stockholm, Sweden)·2002
Same author

Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: a competing risks analysis.

British journal of cancer·2001
Same author

Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2001
Same author

A pilot study of postoperative CHART and CHARTWEL in head and neck cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2001
Same journal

Pathological characteristics and prognosis of very young patients with early breast cancer: a comparative analysis with older patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

First-in-human quantitative [¹⁵O]H₂O PET imaging of tumour blood flow at rest and during exercise in lymphoma patients.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Evaluation of 3D-CRT vs. VMAT for radiotherapy of whole breast with simultaneous integrated boost.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Detection of disease recurrence in real-world patients with completely resected stage III cutaneous melanoma.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Diagnostic pathways for lung cancer patients in Denmark: General practice events, first referral and stage at diagnosis.

Acta oncologica (Stockholm, Sweden)·2026
Same journal

Oncological outcome and immune-checkpoint-blockade-induced toxicities in patients with cervical cancer - a Norwegian real-world cohort.

Acta oncologica (Stockholm, Sweden)·2026
See all related articles

Advances in radiotherapy aim to improve tumor control and reduce treatment side effects. This study examines factors that enhance patient benefits in cancer therapy.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Radiotherapy is a cornerstone of cancer treatment.
  • Improving treatment efficacy while minimizing side effects is crucial.
  • Understanding influencing factors can optimize patient outcomes.

Purpose of the Study:

  • To identify key factors for enhancing tumor control in radiotherapy.
  • To explore strategies for reducing early and late treatment-related morbidity.
  • To provide a comprehensive overview of benefits in cancer patient care.

Main Methods:

  • Literature review of radiotherapy advancements.
  • Analysis of factors affecting treatment outcomes.
  • Consideration of clinical and technical aspects.

Related Experiment Videos

Main Results:

  • Tumor control is directly influenced by radiation dose and fractionation.
  • Minimizing damage to surrounding healthy tissues reduces morbidity.
  • Patient-specific factors and treatment planning are critical.

Conclusions:

  • Optimizing radiotherapy involves balancing tumor eradication with organ preservation.
  • Further research into novel techniques can improve therapeutic ratios.
  • Personalized approaches are key to maximizing patient benefit in radiation oncology.